Monograph Details
|
|
Dermatological Disorders
> Miscellaneous dermatological conditions
|
|
SOLAQUIN |
| Manufacturer |
|
Valeant Pharmaceuticals, Inc |
| Legal Classification |
|
OTC |
| Pharmacological Class |
|
Depigmenting agent + sunscreens. |
| Generic Name |
|
Hydroquinone 2%, ethyldihydroxypropyl PABA 5%, dioxybenzone 3%, oxybenzone 2%; crm; contains sulfites. |
| Also |
• SOLAQUIN FORTE
• SOLAQUIN FORTE GEL
|
| Indications |
|
Hyperpigmented skin conditions. |
| Children |
|
Not recommended. |
| Adults |
|
Apply and massage in twice daily; max 2 months. |
| Precautions |
|
Avoid eyes. Use cautiously near lips, eyes, nose. Do 24 hr patch test before use; do not use if itching, vesicle formation, or excessive inflammatory response occurs. Close patient supervision recommended. Discontinue if sensitization occurs. Asthma. Avoid sun or UV light. Pregnancy (Cat.C). Nursing mothers. |
| Adverse Reactions |
|
Irritation, sensitization. |
| How Supplied |
|
All—1oz |
|
|
|
|
